ICER Releases Draft Evidence Report on Therapies for Lupus Nephritis
Also this morning, we published our Draft Evidence Report assessing the comparative clinical effectiveness and value of voclosporin (Aurinia Pharmaceuticals) [...]
ICER Publishes Evidence Report on Therapies for High Cholesterol
This morning ICER issued the Evidence Report assessing the comparative clinical effectiveness and value of inclisiran (Novartis), bempedoic acid (Nexletol®, [...]
Drug price hikes without new evidence upped spending by $1.2B
The Institute for Clinical and Economic Review (ICER) published its second-ever report on Unsupported Price Increases (UPI) last week, compiled from data [...]
Value-Based Purchasing Rule For Medicaid Rx Drugs
Writing in Health Affairs, outgoing CMS Administrator Seema Verma touts how the Trump Administration helped paved the way for more [...]
New Program in Pharmaceutical Value Assessment and Communications Launched by University of Florida
The University of Florida (UF) College of Pharmacy’s online graduate program in pharmaceutical outcomes and policy today announced the launch [...]
How Will the Role of Medical Communication Professionals Evolve by 2025?
As a new year begins, this article dives deeper into 5 areas that global contributors identified when asked, “How will [...]
AMCP Executive Fellowship in Health Care Association Leadership
In January 2021, AMCP launched the Executive Fellowship in Health Care Association Leadership. This immersive, year-long training program provides a [...]
Democrats Have Their Best Shot Yet at Letting Medicare Negotiate Drug Prices
Democrats have their best shot in more than a decade to deliver on one of the party’s central health care [...]
ISPOR Short Course: Intro To Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources
Real-world observational studies require strong principles of epidemiologic study design and complex analytical methods to strengthen causal inferences. This course [...]
Take Your Market Access to the Next Level With This Free E-book
The world of market access is changing. Cloud computing and software as a service have created new opportunities and more [...]
Cigna Sees Cost Savings, Improved Member Engagement in Study
Cigna is seeing notable savings and improved member engagement through its integrated benefits plans, according to a new study. On [...]
Using Real World Data to Close Rare Disease Gap
Rare disease research and treatment development is uniquely challenging given the limited understanding of rare and genetic diseases. De-identified, real-world [...]
xCures Announces Collaboration with CancerCompass
Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures' platform and services.Consumers who [...]
Komodo Health Acquires Mavens
Today, Komodo Health announced the acquisition of Mavens, a leader and pioneer in cloud-based technology solutions for life sciences. The acquisition brings [...]
Associate Editor Roles – IJTAHC
The International Journal of Technology Assessment in Health Care (IJTAHC) is a journal of Cambridge University Press and a key [...]
How a Former Health Care Executive Became a Health Care Whistleblower
Former health care executive Wendell Potter spent part of 2020 publishing high-profile apologies for the work he used to do — the lies [...]
COVID-19 Trial Tracker Updates
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, [...]
(Podcast) Bridge the City: Opportunity Costs of Healthcare in the US
Researchers David Vanness and James Lomas joined the Bridge the City podcast to explain the conclusions of their new paper, [...]
[Podcast] How Doctors Can Be a Part of the Solution
In the final episode of our podcast's inaugural season, neurologist Jason Crowell and ICER's President Steve Pearson discuss what physicians [...]
3 Ways That Payers Leveraged Artificial Intelligence in 2020
Payers used artificial intelligence to drive towards key objectives in 2020. Artificial intelligence is not a new technology, with the [...]
Aligning HEOR/RWE Procurement with Finance
Procurement is a business function that offers so much in the way of value. However, its not always easy to [...]
State Level Action in Response to ICER’s Unsupported Price Increase Report
In ICER’s latest report on Unsupported Price Increases (UPI), we determined that 7 of the 10 costliest US drug-price hikes [...]
Janet Woodcock to be Acting FDA Commissioner
Janet Woodcock is set to be the most powerful person at the FDA in less than a week. The veteran [...]
Amgen Tops Cost Watchdog’s Price Gougers List
In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s [...]
The American Public’s Priorities for the New President and Congress
In a post-election Politico/Harvard poll, an overwhelming 87% of the respondents indicated that “taking federal government action to lower prescription [...]